Viking Therapeutics company information

바이킹 테라퓨틱스NASDAQ:VKTX · Nasdaq · Healthcare · sector #17

$28.38-3.07%

2026-10-06 close

Viking Therapeutics's company information is shown as of 2026-10-06. It is a security listed on Nasdaq, ticker VKTX. There are 11 published related companies.

About this company

Viking Therapeutics last closed at $28.38 (-3.07%) on 2026-10-06. Listed on Nasdaq.

1 guru reporting 13F holdings

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F is quarterly and may be filed up to 45 days later.

Curated gurus reporting this holding

A curated subset of well-known investors — not the full institutional ownership.

Bridgewater Associates87,859주2026-06-30 · 증감 +16630주

Suppliers, competitors and related stocks

Eli LillyCompetitor
비만·대사질환 치료제 개발에서 직접 경쟁
Novo NordiskCompetitor
GLP-1 계열 비만 치료제 시장의 핵심 경쟁사
PfizerCompetitor
비만 치료제 및 대사질환 파이프라인 경쟁
AmgenCompetitor
차세대 비만 치료제 개발 경쟁사
Structure TherapeuticsCompetitor
경구 GLP-1 계열 등 비만 치료제 경쟁
AltimmuneCompetitor
비만·대사질환 치료제 개발 경쟁사
Arrowhead PharmaceuticalsCompetitor
비만 및 간질환 관련 RNA 치료제 경쟁
Ionis PharmaceuticalsCompetitor
대사·희귀질환 분야 RNA 치료제 경쟁
GLP-1Related theme
비만 치료의 핵심 약물 기전으로 시장 테마를 형성
Obesity drugRelated theme
비만 치료제 시장 성장 기대와 직접 연관된 테마
Metabolic diseaseRelated theme
비만·MASH 등 대사질환 파이프라인의 핵심 테마

Quantus Signal · live data · not investment advice · Privacy Policy